Goconnect Limited News Today

GoConnect Ltd (NSX:GO8) holds 43.5% of Go Green Holdings Ltd which holds a major interest of 24% in COVIRIX Medical. The proposed merger values COVIRIX Medical at US$617 million which, when consummated, will involve NIVF issuing its shares at a deemed price of US$6 per share.

GoConnect Limited (NSX:GO8) advise that COVIRIX Medical and Numolux Group have entered into a strategic partnership for anti-viral drug development platform.

The Directors of GoConnect Limited provide the following report for the quarter ended 30 June 2023. GO8 continued to derive income from sale of investment. Go Green Holdings Ltd co-founded by GO8 is...

GoConnect Limited (NSX:GO8) has been established since August 1999 as a media communications company. Since 1999 and until 2015 when it co-founded Go Green Holdings, its core business specialised in the online delivery of interactive audio and video contents via its unique and proprietary technology.

GoConnect Limited (NSX:GO8) is pleased to advise that COVIRIX Medical Pty Ltd, of which Go Green Holdings Ltd has a 24% interest, has been granted a 20 years patent by IP Australia for the companys repurposed antiviral treatment and prevention of pulmonary infections.

GoConnect Limited (NSX:GO8) continued to derive income from sale of investment. However, in the June 2022 quarter, GO8 withheld further sale pending the generation of revenue from a number of investments held by Go Green Holdings Ltd.

GoConnect Limited (NSX:GO8) is pleased to provide a copy of media release received from COVIRIX Medical and US DiaCarta Inc in respect of the establishment of their global partnership.

GoConnect Limited (NSX:GO8) is pleased to provide a copy of an investment research report on COVIRIX Medical Holdings Ltd prepared by Pitt Street Research (PSR) and distributed by Martin Place Securities.

GoConnect Limiteds (NSX:GO8) primary corporate objective is to establish the Company as a strategic investor in a number of businesses that will contribute to the health of the global environment and health of humanity.

GoConnect Limited (NSX:GO8) is pleased to report on successful virology test results recently received by COVIRIX Medical Pty Ltd against the Delta strain of SARS CoV-2.